6. Early Mobilization & Rehabilitation

Quick Recap

Cross-cutting supportive-care protocol — the "E" of the ABCDEF bundle referenced throughout this library (Delirium Screening & Management, Pain Assessment & Sedation Strategy protocols). This topic has a genuinely instructive recent evidence arc: after roughly 15 years of smaller trials and observational data building enthusiasm for aggressive early mobilization, the largest, most rigorous trial to date (TEAM, NEJM 2022) found no benefit and a real safety signal — worth understanding honestly rather than defaulting to "more mobilization is always better."

1. Definition

Early mobilization: physical activity (passive range of motion progressing to active exercise, sitting, standing, and ambulation as tolerated) initiated early in the course of critical illness, including in mechanically ventilated patients, with the goal of mitigating ICU-acquired weakness and improving functional recovery.

ICU-acquired weakness (ICU-AW): a syndrome of generalized muscle weakness developing during critical illness, affecting an estimated ~40% of patients, encompassing critical illness polyneuropathy, critical illness myopathy, or a mixed picture — associated with higher mortality risk, longer hospital stay, and slower functional recovery.

High-intensity vs. usual-care mobilization: the key distinction tested in the most recent, largest trial (TEAM) was not "mobilization vs. no mobilization" but rather early, high-intensity, protocolized mobilization (mobilizing to the highest tolerated level for as long as possible until fatigued) vs. the usual-care level of mobilization already being delivered in contemporary ICUs — an important distinction, since "usual care" in modern ICUs already includes substantial physiotherapy input in many settings, unlike the near-zero-mobilization baseline of two decades ago.

2. Pathophysiology

Critical illness and mechanical ventilation are associated with rapid muscle wasting, driven by a combination of systemic inflammation, disuse atrophy, corticosteroid exposure, neuromuscular blockade, and the catabolic state of critical illness itself (cross-reference Nutrition Support in Critical Illness protocol for the related but distinct nutritional dimension of this catabolic state — nutrition alone does not fully counteract it, and neither, as it turns out, does mobilization alone). Less than 10% of mechanically ventilated patients historically performed any out-of-bed activity, and the mere presence of an endotracheal tube has been identified as an independent negative predictor of physical activity occurring at all — reflecting both genuine clinical barriers and a degree of unwarranted caution that early mobilization research initially sought to overcome.

The mechanistic rationale for mobilization mitigating ICU-AW is intuitive (activity-dependent muscle protein synthesis, prevention of disuse atrophy), but as with several other areas in this library (early high-protein nutrition, tight glycemic control), a mechanistically plausible intervention does not automatically translate into a clinically confirmed outcome benefit when tested rigorously at scale — this is the central lesson of the current evidence base here.

3. Immediate Stabilization (ABCDE) — Mobilization Safety Screening

Not an acute stabilization scenario; the relevant "stabilization" step is a pre-mobilization safety screen, performed before any active mobilization session:

Checklist — before each mobilization attempt:

4. Focused History

• Baseline functional status and mobility prior to this critical illness (essential context for setting realistic goals and interpreting "improvement")
• Duration of mechanical ventilation and sedation to date
• Presence of specific mobilization barriers: hemodynamic instability, unstable fractures, spinal precautions, active bleeding risk, agitation/delirium status
• Prior ICU-acquired weakness or prolonged critical illness episodes if this is a readmission

5. Comprehensive System-wise Examination

• Musculoskeletal: muscle bulk/strength assessment (MRC sum score where feasible), range of motion, contracture risk
• Cardiovascular: hemodynamic reserve/tolerance for upright positioning and activity
• Respiratory: ventilatory reserve for the work of active movement
• Neurological: level of consciousness, ability to follow commands and participate actively vs. requiring passive mobilization only

POCUS integration: bedside muscle ultrasound (e.g., quadriceps/rectus femoris thickness) is used in research settings to quantify muscle mass loss over the ICU stay, though not yet routine clinical practice for individual mobilization decision-making.

6. Syndrome Identification — Reframed as Mobilization-Readiness Classification

• Stable, appropriate for active mobilization: hemodynamically and respiratory stable, adequate consciousness — proceed with individualized, progressive active mobilization
• Unstable, passive mobilization only: hemodynamic/respiratory instability, deep sedation for a specific indication — passive range of motion and positioning, active mobilization deferred until stability achieved
• Barriers present requiring specific modification: agitation/delirium (address per Delirium Screening & Management protocol before or alongside mobilization attempts), unstable fractures/spinal precautions (mobilization plan coordinated with relevant surgical/orthopedic team)

7. Differential Diagnosis — Reframed as "Why Is This Patient Not Mobilizing?"

Must-not-miss (genuinely limiting factors):

• Hemodynamic instability
• Respiratory instability/inadequate reserve
• Unrecognized fracture or spinal instability

Common, often modifiable barriers:

• Oversedation (cross-reference Pain Assessment & Sedation Strategy protocol — this is frequently the single most correctable barrier)
• Delirium/agitation impairing safe participation
• Staffing/resource limitations (physiotherapy availability, nursing time) — a genuine, documented, non-clinical barrier identified across multiple qualitative studies of ICU mobilization practice

Iatrogenic:

• Excessive caution/device anxiety not proportionate to actual clinical risk
• Lack of institutional protocol or unclear safety criteria leading to default inaction

8. Severity/Risk Assessment

MRC sum score: standard bedside tool for quantifying ICU-acquired weakness severity (score <48 suggests clinically significant weakness), used to track trajectory over the ICU stay rather than as a mobilization-readiness gatekeeper per se.

Mobilization-associated adverse event risk: per the TEAM trial (Section 11), adverse events potentially attributable to mobilization (arrhythmia, blood pressure change, desaturation) occurred in 9.2% of the early-mobilization group vs. 4.1% of usual care (OR 2.55, 95% CI 1.33–4.89, p=0.005) — a real, quantified safety signal that should inform individualized risk-benefit discussion, not be dismissed as a trivial or expected finding.

9. Investigations — Not Primarily a Diagnostic Workup

Not applicable in the traditional sense; relevant "investigation" is the pre-mobilization safety screen (Section 3) performed at the bedside before each session.

10. Point-of-Care Ultrasound

Muscle ultrasound (quadriceps/rectus femoris thickness) as a research tool for tracking muscle mass loss; not yet standard clinical practice for individual mobilization decisions.

11. Evidence-Based Management

The Historical Enthusiasm — Foundational Positive Evidence

• Schweickert et al., Lancet 2009: early physical/occupational therapy combined with daily sedation interruption vs. sedation interruption alone — early mobility group showed greater return to independent function, less delirium, faster ventilator liberation (cross-reference Delirium Screening & Management and Post-Extubation Failure & Reintubation protocols, where this trial is also referenced for its sedation-interruption findings)
• Numerous subsequent smaller trials, systematic reviews, and observational studies built substantial enthusiasm for early, aggressive mobilization protocols through the 2010s, and early mobilization was incorporated into major bundled-care frameworks (SCCM ICU Liberation Bundle) as a core recommended element

The Definitive, Large-Scale Test — TEAM Trial (2022)

• TEAM Trial (Hodgson et al., NEJM 2022, n=750, international, multicenter): mechanically ventilated adults randomized to early, high-intensity mobilization (sedation minimization plus daily physiotherapy, mobilized to the highest tolerated level for as long as possible until fatigued) vs. usual care (the mobilization level already being provided in each participating ICU)
• Primary outcome — days alive and out of hospital at 180 days: median 143 days (early mobilization) vs. 145 days (usual care), absolute difference −2.0 days (95% CI −10 to 6, p=0.62) — no significant difference, and the point estimate actually favored usual care, though not significantly
• No improvement in key secondary functional outcomes at hospital discharge or 180 days
• Safety signal: adverse events potentially attributable to mobilization occurred in 9.2% (early mobilization) vs. 4.1% (usual care) (p=0.005) — predominantly arrhythmia, blood pressure changes, and desaturation; 8 serious adverse events total, 7 of which occurred in the early-mobilization group (5 arrhythmias, a desaturation episode, and a cerebrovascular accident that resulted in persistent unilateral weakness)
• Important context: the "usual care" comparator group in TEAM already received substantial physiotherapy input by contemporary standards — this was not a comparison against near-zero mobilization, which somewhat tempers direct comparison to the earlier, smaller trials (like Schweickert 2009) conducted in a lower-baseline-mobilization era

Reconciling TEAM with the Broader Meta-Analytic Evidence

• 2023 systematic review/meta-analysis (Wang et al.): systematic early mobilization had no significant effect on short- or long-term mortality, but could reduce ICU length of stay and duration of mechanical ventilation — suggesting some process/resource-utilization benefit persists even without a clear mortality or long-term functional signal
• NEJM Evidence meta-analysis (15 trials, 11 countries, 2,703 participants): pooled analysis of 6 trials reporting the primary "days alive and out of hospital" outcome found a mean increase of 4.28 days with early active mobilization (95% CI −4.46 to 13.03, I²=41%) — a Bayesian analysis found a 75.1% probability that early mobilization increases days alive and out of hospital, a moderately favorable but genuinely uncertain probability, not a confident conclusion in either direction
• Practical synthesis: TEAM, as the single largest and most rigorous trial, found no benefit and a real safety signal specifically for a high-intensity, uniformly applied protocol. The broader pooled evidence remains more favorable but genuinely uncertain (75% probability of benefit is meaningfully short of confident certainty). This does NOT mean mobilization should be abandoned — it means the routine, one-size-fits-all pursuit of maximal early mobilization intensity for every patient is not well-supported, and an individualized approach based on patient-specific stability and trajectory, rather than a rigid high-intensity protocol applied uniformly, is the more defensible current practice

Practical Approach

• Individualize mobilization intensity and timing based on current hemodynamic/respiratory stability and trajectory, rather than applying a fixed high-intensity protocol to all patients regardless of status
• Prioritize sedation minimization (cross-reference Pain Assessment & Sedation Strategy protocol) as a foundational enabler of mobilization, since oversedation remains one of the most consistently identified, modifiable barriers
• Address delirium/agitation (cross-reference Delirium Screening & Management protocol) as part of, not separate from, mobilization readiness
• Maintain physiotherapy involvement and daily assessment of mobilization appropriateness, without mandating a specific maximal-intensity target for every patient
• Recognize that "usual care" in a well-resourced, modern ICU already delivering substantial physiotherapy input may not have much additional benefit to gain from a more aggressive, standardized protocol — the marginal benefit of intensifying an already-reasonable baseline appears to be the key open question, not whether mobilization matters at all

12. Organ Support

Interacts directly with Pain Assessment & Sedation Strategy (sedation depth is a primary determinant of mobilization feasibility) and Delirium Screening & Management (agitation/delirium status affects safe participation) protocols — this protocol should not be applied in isolation from those two.

13. Disease-Specific Therapy — Not Applicable

This is a process/rehabilitation protocol rather than a pharmacotherapy one; the relevant "therapy" is physiotherapy/occupational therapy delivery itself, individualized per Section 11.

14. Consultation Matrix

15. Monitoring Framework

• Clinical: hemodynamic/respiratory tolerance during and after mobilization sessions, documented systematically
• Functional trajectory: MRC sum score trend, mobility milestone achievement (sitting, standing, ambulating) tracked over the ICU stay
• Escalation triggers: any adverse event during mobilization (arrhythmia, desaturation, hemodynamic change) → reassess readiness criteria and individualize approach for subsequent sessions rather than reflexively continuing an unmodified protocol

16. ICU Bundle Checklist ("E" of ABCDEF, Daily)

17. Complications

Early:

• Arrhythmia, hemodynamic instability, oxygen desaturation during mobilization attempts — quantified in TEAM at a real, non-trivial rate (9.2% with high-intensity mobilization)
• Device dislodgement (lines, tubes) — a theoretical and commonly cited concern, though not the dominant adverse event category in TEAM specifically
• Falls or injury during active mobilization

Late:

• Persistent ICU-acquired weakness and functional disability if mobilization is inadequately pursued
• Post-intensive care syndrome physical domain impairment

Prevention: individualized, stability-matched mobilization approach; sedation minimization; delirium/agitation management as a prerequisite rather than an afterthought

Rescue: prompt recognition and management of mobilization-associated adverse events; reassessment of readiness criteria before resuming

18. Escalation & De-escalation

Escalation (of mobilization intensity): as hemodynamic/respiratory stability improves and sedation is weaned → progressively advance mobilization level (passive → active → sitting → standing → ambulation), individualized to trajectory rather than a fixed timeline.

De-escalation: any adverse event or deterioration in stability → step back to a lower-intensity or passive approach, reassess before re-attempting active mobilization.

19. ICU Discharge Criteria (Mobilization-Relevant Context)

Cross-reference ICU Discharge Criteria & Step-Down protocol. Mobilization-specific consideration: current functional/mobility status and ongoing rehabilitation plan communicated clearly at transfer, since receiving ward teams may have different physiotherapy resource availability than the ICU.

20. Documentation & Medicolegal Checklist

• Pre-mobilization safety screen documented for each session
• Mobilization level achieved and any adverse events documented
• Rationale for mobilization intensity/timing decisions documented, particularly for patients where a more cautious or more aggressive approach than typical is chosen
• MRC sum score or equivalent functional assessment trend documented
• Rehabilitation plan communicated at any care transition

21. Key Guidelines

• SCCM ICU Liberation Bundle (ABCDEF): continues to recommend early mobilization as a core bundle element, though current guideline language reflects the more nuanced, individualized approach supported by TEAM rather than a specific mandated intensity/timing protocol
• Guidelines historically suggested mobilization "without recommending a specific time or regimen," reflecting the inconsistent findings across the smaller trials that preceded TEAM — TEAM itself has reinforced rather than resolved this deliberate lack of prescriptiveness

22. Landmark Trials

23. Controversies

• TEAM's neutral-to-cautionary result vs. two decades of prior enthusiasm: this is a genuine, important recalibration — early mobilization had been incorporated into major bundled-care recommendations based substantially on smaller trials, observational data, and biological plausibility; TEAM, as the largest and most rigorous test, found neither benefit nor safety on the primary outcome, with a real adverse event signal. This should prompt genuine reconsideration of uniform, high-intensity mobilization protocols, not dismissal of the trial as an outlier.
• "Usual care" comparator drift over time: TEAM's usual-care arm already received meaningful physiotherapy input, unlike the near-zero-mobilization baseline in earlier trials like Schweickert 2009 — this makes cross-trial comparison genuinely difficult, and may partly explain why TEAM's results differ from older, smaller positive trials rather than TEAM simply "refuting" them outright.
• Reconciling TEAM with the pooled meta-analytic evidence: the pooled 75.1% Bayesian probability of benefit is a genuinely intermediate, uncertain finding — not strongly supportive, not strongly refuting. Clinicians should resist the urge to over-interpret either TEAM alone or the pooled meta-analysis alone as definitive; the honest current state is genuine uncertainty about the value of intensifying mobilization beyond a reasonable contemporary baseline, even as the broader principle that mobilization matters more than immobility remains intact.
• Which patients benefit most, if any subgroup does: TEAM's authors themselves explicitly called for future research to identify which patients benefit most from early mobilization, rather than treating the intervention as uniformly beneficial or uniformly neutral — this remains a genuinely open, unresolved question rather than a settled area for risk-stratified practice.

24. References

1. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874-1882.
2. TEAM Study Investigators and the ANZICS Clinical Trials Group. Early active mobilization during mechanical ventilation in the ICU. N Engl J Med. 2022;387(19):1747-1758.
3. Wang L, Hua Y, Wang L, Zou X, Zhang Y, Ou X. The effects of early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis. Front Med. 2023;10:1202754.
4. The effect of mobilization at 6 months after critical illness — meta-analysis. NEJM Evid. 2023.
5. Tipping CJ, Harrold M, Holland A, Romero L, Nisbet T, Hodgson CL. The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review. Intensive Care Med. 2017;43:171-183.
6. Moss M. Early mobilization of critical care patients — still more to learn. N Engl J Med. 2022;387(19):1807-1808.
7. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol (ABC Trial). Lancet. 2008;371:126-134.
8. The Washington Manual of Critical Care, 4th ed. 2025 — comprehensive ICU care/mobility chapter.
9. ICU Protocols: A Step-wise Approach, 2nd ed. — comprehensive ICU care chapter.